Delayed multiple sclerosis diagnosis underscores need for urgent research and awareness boost, report find

FHS
May 30, 2024
2:06 am

A new report from MS Australia reveals that the average time to diagnose multiple sclerosis is nearly four years, highlighting the urgent need for increased research investment and enhanced awareness.

CDMO: Indena’s Long-Term Vision – Pharmaceutical Technology

Share this article Credit: Kitreel via Shutterstock. Indena CDMO origin: Founded in 1921 by Carlo Boccaccio Inverni and Biagio Alberto Della Beffa and headquartered in

February 29, 2024

Google Gemini and Bard pass the ophthalmology board examination

The performance of two AI chatbots in the ophthalmology board examination.

April 16, 2024

Sage Therapeutics fires 40% of staff after FDA rejected MDD bid – Pharmaceutical Technology

Sage Therapeutics announced plans to layoff 40% of workforce as it plans to launch its postpartum depression drug later this year. Image Credit: Shutterstock /

September 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.